Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia

Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia. Our data com...

Full description

Bibliographic Details
Main Authors: Barbka Repic Lampret, Mojca Zerjav Tansek, Blaz Groselj, Jaka Sikonja, Tadej Battelino, Urh Groselj
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Data in Brief
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S235234092200138X
_version_ 1818315215797747712
author Barbka Repic Lampret
Mojca Zerjav Tansek
Blaz Groselj
Jaka Sikonja
Tadej Battelino
Urh Groselj
author_facet Barbka Repic Lampret
Mojca Zerjav Tansek
Blaz Groselj
Jaka Sikonja
Tadej Battelino
Urh Groselj
author_sort Barbka Repic Lampret
collection DOAJ
description Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia. Our data complements the results from the original research article by Tansek et al., 2012 [1]. We performed a BH4-loading test in 32 patients after four days of increased protein intake (2000 mg/kg body weight). Blood sampling was performed 96, 72, 48, 24, 16 h, and moments before oral administration of BH4 in a dose of 20 mg/kg body weight. Additional blood samples were collected 8 and 24 h after its administration. Phenylalanine (Phe) and Tyrosine (Tyr) levels were determined from dried blood spots by tandem mass spectrometry. Phe/Tyr-ratio reached a plateau after three days of increased dietary protein intake. Fifteen patients (47%) responded to BH4, defined as a decrease of Phe-of at least 30% after 24 h of BH4 administration. Phe/Tyr-ratios were significantly higher in non-responders compared to responders. In the responder group, Phe/Tyr-ratios decreased in average of 67% (p = 0.001) and 45% (p = 0.001) after 8 and 24 h of BH4 administration, respectively. Phe/Tyr-ratio decreased after 8 h of drug administration also in the non-responder group, but not 24 h after administration.
first_indexed 2024-12-13T09:02:00Z
format Article
id doaj.art-a4777b2c15f246c4a7c4c6f66cd74867
institution Directory Open Access Journal
issn 2352-3409
language English
last_indexed 2024-12-13T09:02:00Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series Data in Brief
spelling doaj.art-a4777b2c15f246c4a7c4c6f66cd748672022-12-21T23:53:09ZengElsevierData in Brief2352-34092022-04-0141107926Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemiaBarbka Repic Lampret0Mojca Zerjav Tansek1Blaz Groselj2Jaka Sikonja3Tadej Battelino4Urh Groselj5Clinical Institute for Special Laboratory Diagnostics, University Children's Hospital, UMC Ljubljana, Ljubljana 1000, SloveniaDepartment of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Ljubljana 1000, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana 1000, SloveniaFaculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia; Institute of Oncology Ljubljana, Ljubljana 1000, SloveniaFaculty of Medicine, University of Ljubljana, Ljubljana 1000, SloveniaDepartment of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Ljubljana 1000, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana 1000, SloveniaDepartment of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Ljubljana 1000, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia; Corresponding author at: Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Bohoriceva 20, Ljubljana 1000, SloveniaBlood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia. Our data complements the results from the original research article by Tansek et al., 2012 [1]. We performed a BH4-loading test in 32 patients after four days of increased protein intake (2000 mg/kg body weight). Blood sampling was performed 96, 72, 48, 24, 16 h, and moments before oral administration of BH4 in a dose of 20 mg/kg body weight. Additional blood samples were collected 8 and 24 h after its administration. Phenylalanine (Phe) and Tyrosine (Tyr) levels were determined from dried blood spots by tandem mass spectrometry. Phe/Tyr-ratio reached a plateau after three days of increased dietary protein intake. Fifteen patients (47%) responded to BH4, defined as a decrease of Phe-of at least 30% after 24 h of BH4 administration. Phe/Tyr-ratios were significantly higher in non-responders compared to responders. In the responder group, Phe/Tyr-ratios decreased in average of 67% (p = 0.001) and 45% (p = 0.001) after 8 and 24 h of BH4 administration, respectively. Phe/Tyr-ratio decreased after 8 h of drug administration also in the non-responder group, but not 24 h after administration.http://www.sciencedirect.com/science/article/pii/S235234092200138XPhenylketonuriaPhenylalanine-to-tyrosine ratioTetrahydrobiopterinBH4-responsivenessHyperphenylalaninemiaTandem mass spectrometry
spellingShingle Barbka Repic Lampret
Mojca Zerjav Tansek
Blaz Groselj
Jaka Sikonja
Tadej Battelino
Urh Groselj
Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
Data in Brief
Phenylketonuria
Phenylalanine-to-tyrosine ratio
Tetrahydrobiopterin
BH4-responsiveness
Hyperphenylalaninemia
Tandem mass spectrometry
title Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
title_full Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
title_fullStr Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
title_full_unstemmed Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
title_short Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia
title_sort data on phenylalanine to tyrosine ratios in assessment of tetrahydrobiopterin bh4 responsiveness in patients with hyperphenylalaninemia
topic Phenylketonuria
Phenylalanine-to-tyrosine ratio
Tetrahydrobiopterin
BH4-responsiveness
Hyperphenylalaninemia
Tandem mass spectrometry
url http://www.sciencedirect.com/science/article/pii/S235234092200138X
work_keys_str_mv AT barbkarepiclampret dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia
AT mojcazerjavtansek dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia
AT blazgroselj dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia
AT jakasikonja dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia
AT tadejbattelino dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia
AT urhgroselj dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia